Hypochlorous Acid

次氯酸

Report date: 2025/10/27 17:55:12

Base Information

Drug NameHypochlorous Acid
Drug Alias NameAvenovaPR-022PR-013
ClassificationSmall molecules
Mechanisms of ActionImmunomodulatorsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Dermatitis, AtopicCataract +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRealm Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPRN Physician Recommended Nutriceuticals LLCAcumen Health Holdings LLCLoma Linda University
Inactive CompaniesPontificia Universidad JaverianaRealm Therapeutics Inc
Active IndicationsCataractEndophthalmitis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Dermatitis, AtopicConjunctivitis, Allergic +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia